תוצאות חיפוש - Sender Herschorn

Refine Results
  1. 1
    The artificial urinary sphincter is the treatment of choice for post–radical prostatectomy incontinence

    The artificial urinary sphincter is the treatment of choice for post–radical prostatectomy incontinence מאת Sender Herschorn

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Oxybutynin Chloride for Geriatric Urinary Dysfunction: a Double-blind Placebo-controlled Study

    Oxybutynin Chloride for Geriatric Urinary Dysfunction: a Double-blind Placebo-controlled Study מאת Maria L. Zorzitto, P. J. Holliday, M. A. S. Jewett, Sender Herschorn, Geoff Fernie

    יצא לאור 1989
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  3. 3
    Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)

    Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR) מאת Adrian Wagg, David R. Staskin, Eli Engel, Sender Herschorn, Rita M. Kristy, Carol R. Schermer

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    Surgical treatment of stress incontinence in men

    Surgical treatment of stress incontinence in men מאת Sender Herschorn, Homero Bruschini, Craig V. Comiter, P. Grise, Tomáš Hanuš, Ruth Kirschner‐Hermanns, Paul Abrams

    יצא לאור 2009
    קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  5. 5
    OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

    OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies... מאת K.D. Sievert, Christopher R. Chapple, Sender Herschorn, Mrinmayee Joshi, Jihao Zhou, Christopher Nardo, Victor W. Νitti

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)

    Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR) מאת Tomas L. Griebling, Noll L. Campbell, Jeffrey Mangel, David R. Staskin, Sender Herschorn, Dina Elsouda, Carol R. Schermer

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Safety and tolerability of the β <sub>3</sub> ‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial

    Safety and tolerability of the β <sub>3</sub> ‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week r... מאת Victor W. Νitti, Christopher R. Chapple, C. Walters, Mary Beth Blauwet, Sender Herschorn, Ian Milsom, Sascha Auerbach, P. Radziszewski

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

    Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo מאת Christopher R. Chapple, Francisco Cruz, Linda Cardozo, David R. Staskin, Sender Herschorn, Nurul Choudhury, Matthias Stoelzel, John Heesakkers, Emad Siddiqui

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  9. 9
    The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

    The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results... מאת José E. Batista, H. Kölbl, Sender Herschorn, Tomasz Rechberger, J. Cambronero, M Halaška, Alex Coppell, Mathilde Kaper, Moses Huang, Emad Siddiqui

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis

    Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis מאת Christopher J.D. Wallis, Refik Saskin, Richard Choo, Sender Herschorn, Ronald Kodama, Raj Satkunasivam, Prakesh S. Shah, Cyril Danjoux, Robert K. Nam

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  11. 11
    Surgery for post-prostatectomy urinary incontinence: Update from the 7th ICI

    Surgery for post-prostatectomy urinary incontinence: Update from the 7th ICI מאת Márcio Augusto Averbeck, Eric Chung, Argimiro Collado Serra, Craig V. Comiter, Michael L. Guralnick, Sender Herschorn, Anand Singla, Howard B. Goldman

    יצא לאור 2024
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  12. 12
    Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies

    Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies מאת Andrea Tubaro, José E. Batista, Victor W. Νitti, Sender Herschorn, Christopher R. Chapple, Mary Beth Blauwet, Emad Siddiqui, Moses Huang, Matthias Oelke

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  13. 13
    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study)

    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study) מאת Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen, Dudley Robinson

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  14. 14
    Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies

    Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase... מאת Victor W. Νitti, V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn, J. Cambronero, J.C. Angulo, Mary Beth Blauwet, Caroline A. Dorrepaal, Emad Siddiqui, Nancy Martin

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  15. 15
    Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

    Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A... מאת Marcus J. Drake, Christopher R. Chapple, Adil Esen, Stavros Athanasiou, J. Cambronero, David Mitcheson, Sender Herschorn, Tahir Saleem, Moses Huang, Emad Siddiqui, Matthias Stölzel, Claire Herholdt, Scott MacDiarmid

    יצא לאור 2016
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  16. 16
    Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

    Association Between Use of Antithrombotic Medication and Hematuria-Related Complications מאת Christopher J.D. Wallis, Tristan Juvet, Yuna Lee, Rano Matta, Sender Herschorn, Ronald Kodama, Girish S. Kulkarni, Raj Satkunasivam, William Geerts, Anne McLeod, Steven A. Narod, Robert K. Nam

    יצא לאור 2017
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  17. 17
    Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)

    Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from... מאת Michael Kennelly, Francisco Cruz, Sender Herschorn, Paul Abrams, Kadir Önem, Viktor Kibanov Solomonov, Elena del Rosario Figueroa Coz, A. Manu-Marin, Antonella Giannantoni, Catherine Thompson, Claire Vilain, Magali Volteau, P. Denys

    יצא לאור 2022
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  18. 18
    OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

    OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology מאת David A. Ginsberg, Francisco Cruz, Sender Herschorn, Angelo E. Gousse, V. Keppenne, Philip J. Aliotta, Karl‐Dietrich Sievert, Mitchell F. Brin, Brenda Jenkins, Catherine Thompson, Wayne Lam, John Heesakkers, Cornelia Haag‐Molkenteller

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  19. 19
    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (S... מאת Christian Gratzke, Rob van Maanen, Christopher R. Chapple, Paul Abrams, Sender Herschorn, Dudley Robinson, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Sang Jin Yoon, С Х Аль-Шукри, Tomasz Rechberger, Elizabeth R. Mueller

    יצא לאור 2018
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  20. 20
    Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy

    Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy מאת Scott MacDiarmid, С Х Аль-Шукри, Jack Barkin, Aino Fianu-Jonasson, P. Grise, Sender Herschorn, Tahir Saleem, Moses Huang, Emad Siddiqui, Matthias Stölzel, Claire Hemsted, Jameel Nazir, Zalmaï Hakimi, Marcus J. Drake

    יצא לאור 2016
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: